Mutation status among patients with sinonasal mucosal melanoma and its impact on survival

Moran Amit, Samantha Tam, Ahmed S. Abdelmeguid, Dianna B. Roberts, Yoko Takahashi, Shaan M. Raza, Shirley Y. Su, Michael E. Kupferman, Franco Demonte, Ehab Y. Hanna

Research output: Contribution to journalArticle

12 Scopus citations

Abstract

Background:Sinonasal mucosal melanoma (SNMM) comprises <1% of all melanomas and lacks well-characterised molecular markers. Our aim was to determine the frequencies of common mutations and examine their utility as molecular markers in a large series of primary SNMMs.Methods:SNMM patients seen at our institution from August 1991 through July 2016 were identified. Genomic DNA was extracted from 66 formalin-fixed paraffin-embedded tumours and screened for mutations by direct sequencing. We investigated the association of mutations with clinicopathological features and survival outcomes.Results:Overall, 41% (27 out of 66) of the SNMMs harboured mutations. BRAF and KIT mutations were identified in 8% (five patients) and 5% (three patients) of SNMMs, respectively, whereas NRAS mutations were detected in 30% (20 patients) of SNMMs. Mutation rates in these oncogenes were similar between SNMMs located in the paranasal sinuses and those in the nasal cavity (30% and 13%, respectively, P=0.09). In a multivariate analysis, patients with negative margins had significantly better overall survival (hazard ratio 5.43, 95% confidence interval 1.44-21.85, P=0.01) and disease-specific survival (hazard ratio 21.9, 95% confidence interval 3.71-180, P=0.0004). The mutation status of the tumours showed no association with survival outcomes.Conclusions:In SNNM, mutation status does not affect survival outcomes, but NRAS mutations are relatively frequent and could be targeted in this disease by MEK inhibitors.

Original languageEnglish (US)
Pages (from-to)1564-1571
Number of pages8
JournalBritish journal of cancer
Volume116
Issue number12
DOIs
StatePublished - Jun 6 2017

    Fingerprint

Keywords

  • BRAF
  • CKIT
  • NRAS
  • melanoma
  • mucosal
  • survival

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this